BCAM and acquired polycythemia vera: In human polycythemia vera RBC with the V617F mutant JAK2, there is an upregulation of Rap1-GTP expression, increased Akt activity, elevated phosphorylation levels of Lu/BCAM and enhanced RBC adhesion to laminin compared to wild-type JAK2 [50,51].